Main > A1. CORP. INDEX. Nn-Nz > Novartis /P C2
This data is not available for free
Novartis /P C2's subsections
2000. 05.22.2000. (Agriculture)
2001. 01.22.2001. (Genomics Deal)
2001. 03.05.2001. (Natural Prodt.)
2001. 04.02.2001. (Parent of)
2001. 05.08.2001. (Allergy/Asthma)
2001. 09.19.2001. (Cyclosporin)
2001. 11.17.2001. (Parent of)
2002. 03.20.2002. (IBS)
2002. 11.04.2002. (Parent of)
2002. 12.02.2002. (Historics)
2003. 01.27.2003. (Roche)
2003. 03.17.2003. (Ranking)
2003. 03.18.2003. (Executive)
2003. 03.18.2003. (Urology)
2003. 04.21.2003. (Ophthalmology)
2003. 06.22.2003. (Allergy/Asthma)
2004. 08.23.2004. (Singapore Base)
2004. 11.22.2004. (Natural Prodt.)
2004. 12.13.2004. (COX-2 Inhibitor)
2005. 01.10.2005. (Infinity Deal)
2005. 02.07.2005. (Diabetes)
2005. 06.06.2005. (Acq.: Hexal)
2005. 06.06.2005. (Anadys Pharma.)
2005. 06.06.2005. (Hybridon Inc)
2005. 06.06.2005. (MorphoChem AG)
2005. 06.13.2005. (InnoCentive)
2005. 08.29.2005. (Bladder Cancer)
2005. 09.05.2005. (Chiral Catalysi)
2005. 09.05.2005. (SFC>CSP>Anal.)
2005. 09.12.2005. (RNAi Drugs)
2005. 10.24.2005. (Malaria)
2006. 01.09.2006. (Oncology)
2006. 02.06.2006. (India Patent)
2006. 02.27.2006. (Alnylam)
2006. 02.27.2006. (Singapore)
2006. 11.13.2006. (CN>R&D)
2006. 12.06.2006. (Diabetes)
2007. 04.09.2007. US Clinical Dev
2007. 06.18.2007. Research Manager
2007. 08.13.2007. (Head Corp R&D)
2007. 08.18.2007. (Osteoporosis)
2007. 09.06.2007. (Antibiotics)
2007. 10.08.2007. Head Global Tech
2007. 12.02.2007. (MorphoSys)
2007. 12.03.2007. (Cardio.>HyperT.)
2008. 01.18.2007. (Depression)
2008. 02.01.2008. (Diabetes)
2008. 02.25.2008. (Diabetes)
2008. 02.28.2008. (Oncology)
2008. 03.03.2008. Head Corp. Resear
2008. 03.10.2008. (Oncology)
2008. 03.31.2008. (Cardiology)
2008. 04.07.2008. (Alcon)
2008. 04.08.2008. (Inflammation)
2008. 04.11.2008. (Oncology)
2008. 04.11.2008. (Osteoporosis)
2008. 04.14.2008. (Alcon)
2008. 04.15.2008. (Neuro>Parkinson)
2008. 04.28.2008. (Diabetes)
2008. 04.28.2008. (Ophthalmology)
2008. 05.14.2008. (Cardio.HyperT.)
2008. 10.27.2008. (COO)
2008. 10.27.2008. (Inhal. Deliv.)
2008. 12.01.2008. NA Pharma Bus.
2009. 03.30.2009. Novartis India
2009. 04.30.2009. (Cardio.>HyperT.)
2009. 05.11.2009. Global Discovery
2009. 08.06.2009. Onco.>Kidney C
2009. 08.17.2009. Neuro>MS>IFN Beta
2009. 10.08.2009. Antibiotics
2010. 02.09.2010. Hepato.>HCV
2010. 06.17.2010. Onco.>CML
2010. 10.11.2010. Onco.>Advd. NET
2010. 11.03.2010. Onco.>Brain C.
2010. 12.09.2010. Onco.>Breast C.+T
2010. 12.20.2010. Russia
2011. 02.09.2011. Onco.>Pancreas C
2011. 04.11.2011. Onco.>PI3K Inh.
2012. 02.01.2012. Onco.>GIST
2012. 02.17.2012. Cardio.>HyperT.
2012. 04.26.2012. Onco.>RA+TSC
2012. 08.06.2012. Onco.>Uni. Penn.
2012. 08.15.2012. Ophthalmo.>VMA
2012. 08.26. CV.>Chronic HF-PEF
2012. 08.28.2012. Onco.>MF
2012. 09.05.2012. Pneumo.>CF>TIP
2012. 09.21.2012. Diabetes
2012. 10.01.2012. Pneumo.>COPD G
2012. 10.31.2012. SG BioTech Mfg.
2012. 11.08.2012. R&D Pipeline
2012. 11.20.2012. Influenza Vacc.
2012. 12.15.2012. Cushings Disease
2013. 01.10.2013. Onco.>NCKT>RA>TSC
2013. 01.16.2013. Onco.>Breast C.+E
2013. 01.23.2013. Hema.>NTDT
2013. 02.15.2013. Liver>Transplant
2013. 03.01.2013. Gouty Arthritis
2013. 04.01.2013. IN Patent
2013. 04.19.2013. Ophthalmo.>Glauco
2013. 04.22. Onco.>Melanoma>LGX818
2013. 04.25. Malaria
2013. 05.10. Rheuma.>SJIA
2013. 06.02. Onco.>Breast C.+T+V
2013. 06.24. Derma.>Psoriasis>Bio
2013. 06.27. Neuro.>AD
2013. 07.08. Biological E Ltd.
2013. 08.01. Meningococcal Vac
2013. 08.07. Onco.>Liver C.
2013. 08.20. Muscle>sIBM
2013. 09.06. Cell Therapy Kidney Tr
2013. 10.04. Neuro.>MS>Fingo.
2013. 10.05. Derma.>CSU
2013. 11.11. Blood Transfusion Diag
2013. 11.14. H7N9 Avian Flu Vacc.
2013. 11.22. Share BuyBack..
2013. 12.09. Onco.>CML>Ph+ CML
2014. 01.13. Pneumo.>COPD G+I
2014. 02.17. Onco.>ImmunoTherapy
2014. 02.26. Clin. Trial Data Trans
2014. 03.07. Onco.>PV
2014. 03.21. Derma.>CIU
2014. 03.31. CV.>Chronic HF-REF
2014. 04.03. Onco.>AACR
2014. 04.09. Alcon Appoints
2014. 04.25. Pneumo.>COPD I
2014. 04.29. Onco.>ALK+ NSCLC
2014. 05.05. Endo.>Acromegaly
2014. 05.16. CV.>Acute HF
2014. 05.19. Ophthalmo.>Wet AMD
2014. 06.01. Onco.>Basal Cell C.
2014. 06.01. Onco.>Pres.
2014. 07.15. Alcon & Google
2014. 07.15. Neuro.>AD>Banner
2014. 07.24. Biosimilar Filgrastim
2014. 07.30. Malaria
2014. 08.20. TB Alliance
2014. 09.25. Psoriatic Arthritis
2014. 09.27. Onco.>ALL>CTL019
2014. 09.27. Onco.>Pancreas C.
2014. 10.26. Flu Vacc Bus Sale To
2014. 12.01. Neuro.>PPMS>Fingo.
2014. 12.16. Endo.>Acromegaly
2015. 01.12. Qualcomm
2015. 01.21. Derma.>Psoriasis
2015. 01.23. Meningitis Vacc.
2015. 02.23. Onco.>MM
2015. 03.06. BioSimilar Filgrastim
2015. 03.30. Aduro Biotech
2015. 03.30. Fe Overload
2015. 06.12. Blood Dis.>Chronic ITP
2015. 06.29. Acq. Spinifex Pharma
2015. 07.08. CV.>HF
2015. 07.24. Onco.>Skin>laBCC
2015. 09.01. Neurology Amgen
2015. 09.03. Filgrastim-sndz
2015. 10.21. Acq. Admune Therap.
2015. 10.29. Pneumo.>COPD I+G
2015. 11.20. Onco.>Melanoma
2016. 01.11. Surface Oncology
2016. 01.15. Rheuma.>As & PsA
2016. 02.09. CV.>HF Cigna Aetna
2016. 02.12. Infliximab BioSimilar
2016. 02.26. Onco.>GI NET; Lung NET
2016. 06.15. Malaria
2016. 06.28. Xencor
2016. 07.07. Pneumo.>Asthma
2016. 08.02. Alcon>Glaucoma
2016. 09.23. Periodic Fever Syndrom
2016. 11.21. Acq. Selexys Pharma.
2016. 12.19. Liver Dis.>Conatus
2017. 04.06. Lubris LLC.
2017. 04.28. Onco.>AML &
2017. 06.05. Onco.>Breast C.>IBM
2017. 06.19. BioSimilar RituxiMAb
2017. 06.23. Onco.>NSCLC
2017. 07.13. Onco.>ALL>CTL019
2017. 08.21. Malaria
2017. 08.24. Onco.>Breast C.
2017. 08.30. Onco.>ALL>CTL019
2017. 09.28. UC Berkeley
2017. 11.13. Homology Medicines
2018. 01.24. Ophthalmo.>Gene
2018. 02.14. Infectious Diarrheal
2018. 03.20. Harvard
2018. 03.27. Consumer Healthcare
2018. 04.17. Malaria
2018. 06.29. Plan Alcon Spin-Off
2018. 07.18. Onco.>Breast C.
2018. 10.29. Hepato.>NASH>Pfizer
2019. 03.27. Neuro.>MS>Sipon
2019. 04.01. IFM Thera.>IFM Tre
2019. 05.24. Neuro.>SMA.>USA>OK
2019. 05.24. Onco.>Breast C.
2019. 10.08. Ophthalmo.>Wet AMD
2019. 11.15. Sickle Cell DIS.>Pain
2019. 11.24. Acq. Medicines Company
2020. 03.03. Neuro.>SPMS>CA>OK
2020. 04.02. COVID-19 Treat.
2020. 06.16. AOSD>USA>FDA>OK
2020. 06.17. Rheuma.>nr-axSpA
2020. 08.13. Onco.>Breast C.>CA>OK
2020. 08.20. Neuro.>RMS>USA>OK
2020. 10.28. COVID-19 Molecular Par
2020. 12.16. Neuro.>SMA.>CA>OK
2020. 12.17. Acq. Cadent Therapeuti
2021. 01.11. Onco.>BeiGene
2021. 06.01. Derma.>FDA Approval
2021. 09.21. Ophthalmo.>Patent
2021. 12.22. Acq. Gyroscope Therap.
2021. 12.22. Cardio.>HeFH>USA>OK
2022. 03.08. Voyager Therapeutics
2022. 03.23. Onco.>Prostate C.
2022. 04.06. Rare DISs.>PROS>USA>OK
2022. 05.28. Onco.>FL>USA>OK
2022. 06.22. Onco.>NSCLC>EU>OK
2022. 06.23. Onco.>Solid>USA>OK
2022. 06.30. Acq. Kedalion Therapeu
2023. 06.12. Acq. Chinook Therapeut
2023. 07.17. Acq. by Novartis
2023. 09.05. Sandoz Spin-Off
2023. 10.31. Derma.>HS>USA>OK
2023. 12.06. Hemato.>PNH>USA>OK
2024. 01.07. Acq. Calypso Biotech!
2024. 02.05. Acq. Morphosys AG
2024. 08.08. Nephro.>USA Approval
2024. 08.22. Borealis Biosciences
Chiron Diagnostics/P
Friedrich Miescher Institute/P
Genetic Therapy Inc./P
Genomics Institute/P
Genomics Novartis Foundation C2
Institute Genomic Research/P
Novartis AG/P
Novartis Animal Health/P C2
Novartis Consumer Health/P C2
Novartis Corp./P
Novartis Diagnostics/P C2
Novartis Finance/P
Novartis ForschungsStiftung/P
Novartis Institute For Tropical C2
Novartis Institutes BioMedical C2
Novartis Intl. Pharmaceutical/P
Novartis Pharma GmbH/P C2
Novartis Pharmaceuticals Corp./P C2
Novartis Vaccines/P C2
Novartis Venture Funds C2
Novartris AG/P
Novatis AG/P
Pharma>Ophthalmics C2
Sandoz Pharm. Corp./P
Sandoz Pharmaceuticals Corp./P
Web-Site
Z - OK
Novartis /P C2's products
This section has no products